Cargando…
A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin
Thrombosis is one of the serious complications related to prophylactic balloon occlusion of the abdominal aorta (PBOAA). This study aims to retrospectively analyze the efficacy and safety of continuous low-flow infusion of diluted heparin saline to prevent this complication related to PBOAA and furt...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940061/ https://www.ncbi.nlm.nih.gov/pubmed/31861017 http://dx.doi.org/10.1097/MD.0000000000018446 |
_version_ | 1783484285880107008 |
---|---|
author | Luo, Rongguang Wang, Fen Guan, Yanxing Wan, Junhui Zhang, Wentao Duan, Zhifeng |
author_facet | Luo, Rongguang Wang, Fen Guan, Yanxing Wan, Junhui Zhang, Wentao Duan, Zhifeng |
author_sort | Luo, Rongguang |
collection | PubMed |
description | Thrombosis is one of the serious complications related to prophylactic balloon occlusion of the abdominal aorta (PBOAA). This study aims to retrospectively analyze the efficacy and safety of continuous low-flow infusion of diluted heparin saline to prevent this complication related to PBOAA and further to provide the theory and evidences for using PBOAA. A study was carried out at our hospital from March 2016 to December 2018. Women with pernicious placenta previa (PPP) were treated PBOAA to prevent massive bleeding during CS. According to whether continuous low-flow infusion of diluted heparin saline was used to prevent catheter-related thrombosis or not, they were divided into 2 groups, the test group and the control group. The incidence of thrombosis between the 2 groups was compared and the effective treatment of thrombosis was also discussed. The comparison of nonparametric values was accomplished by using Fisher exact test. Statistical significance was set at P < .05. There were 31 women with PPP who received PBOAA during CS who were included in our study. Six of 19 women in control group (31.6%) developed thrombotic complications, while none of 12 women in test group. There were statistically significant differences in the incidence of thrombosis between the 2 groups (P = .037). There was no statistically significant difference in the amount of estimated blood loss and blood transfusion during CS between the 2 groups, nor was there statistically significant difference in the hospital days after CS (P > .05). All 6 women with thrombotic complications had no positive symptoms and thrombotic sequelae. The managements of thrombus included systemic anticoagulation, catheter-directed thrombolysis, and catheter-directed anticoagulation. One of the 6 women was lost to follow-up, and the thrombus of the other 5 women were completely dissolved. No other adverse outcomes or complications related to PBOAA were observed in all women in this study. Continuous low-flow infusion of diluted heparin saline is a safe procedure when PBOAA is performed for patients with PPP. It can effectively reduce or even avoid thrombosis without increasing intraoperative blood loss during CS for PPP patients. |
format | Online Article Text |
id | pubmed-6940061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-69400612020-01-31 A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin Luo, Rongguang Wang, Fen Guan, Yanxing Wan, Junhui Zhang, Wentao Duan, Zhifeng Medicine (Baltimore) 5600 Thrombosis is one of the serious complications related to prophylactic balloon occlusion of the abdominal aorta (PBOAA). This study aims to retrospectively analyze the efficacy and safety of continuous low-flow infusion of diluted heparin saline to prevent this complication related to PBOAA and further to provide the theory and evidences for using PBOAA. A study was carried out at our hospital from March 2016 to December 2018. Women with pernicious placenta previa (PPP) were treated PBOAA to prevent massive bleeding during CS. According to whether continuous low-flow infusion of diluted heparin saline was used to prevent catheter-related thrombosis or not, they were divided into 2 groups, the test group and the control group. The incidence of thrombosis between the 2 groups was compared and the effective treatment of thrombosis was also discussed. The comparison of nonparametric values was accomplished by using Fisher exact test. Statistical significance was set at P < .05. There were 31 women with PPP who received PBOAA during CS who were included in our study. Six of 19 women in control group (31.6%) developed thrombotic complications, while none of 12 women in test group. There were statistically significant differences in the incidence of thrombosis between the 2 groups (P = .037). There was no statistically significant difference in the amount of estimated blood loss and blood transfusion during CS between the 2 groups, nor was there statistically significant difference in the hospital days after CS (P > .05). All 6 women with thrombotic complications had no positive symptoms and thrombotic sequelae. The managements of thrombus included systemic anticoagulation, catheter-directed thrombolysis, and catheter-directed anticoagulation. One of the 6 women was lost to follow-up, and the thrombus of the other 5 women were completely dissolved. No other adverse outcomes or complications related to PBOAA were observed in all women in this study. Continuous low-flow infusion of diluted heparin saline is a safe procedure when PBOAA is performed for patients with PPP. It can effectively reduce or even avoid thrombosis without increasing intraoperative blood loss during CS for PPP patients. Wolters Kluwer Health 2019-12-20 /pmc/articles/PMC6940061/ /pubmed/31861017 http://dx.doi.org/10.1097/MD.0000000000018446 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 5600 Luo, Rongguang Wang, Fen Guan, Yanxing Wan, Junhui Zhang, Wentao Duan, Zhifeng A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
title | A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
title_full | A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
title_fullStr | A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
title_full_unstemmed | A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
title_short | A retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
title_sort | retrospective analysis of the treatment on abdominal aortic balloon occlusion-related thrombosis by continuous low-flow diluted heparin |
topic | 5600 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940061/ https://www.ncbi.nlm.nih.gov/pubmed/31861017 http://dx.doi.org/10.1097/MD.0000000000018446 |
work_keys_str_mv | AT luorongguang aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT wangfen aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT guanyanxing aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT wanjunhui aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT zhangwentao aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT duanzhifeng aretrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT luorongguang retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT wangfen retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT guanyanxing retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT wanjunhui retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT zhangwentao retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin AT duanzhifeng retrospectiveanalysisofthetreatmentonabdominalaorticballoonocclusionrelatedthrombosisbycontinuouslowflowdilutedheparin |